Anagrelide. a selective inhibitor of thrombopoiesis
Hasselbalch, H.C.; Mourits-Andersen, H.T.; Jensen, B.A.; Nielsen, O.J.
Ugeskrift for Laeger 158(12): 1693-1695
1996
ISSN/ISBN: 0041-5782 PMID: 8644420 Document Number: 458058
Document emailed within 1 workday
Related Documents
Najda, J.; Stella-Hołowiecka, B. 2005: Clinical application of anagrelide as a selective inhibitor of megakaryocyte system Wiadomosci Lekarskie 58(11-12): 665-669Muraki, I. 2001: Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate Hokkaido Journal of Medical Science 76(2): 57-70
Hettich, M.; Thomae, K. 1997: Selective cyclooxygenase-2 inhibitor Der Internist 38(10): 1007
2001: Selective COX-2 inhibitor. Stomach protection--but not always MMW Fortschritte der Medizin 143(25): 60
Goss, P.E.; Tye, L.M. 1997: Anastrozole: a new selective nonsteroidal aromatase inhibitor Oncology 11(11): 1697-1703; Discussion: 1707-1708
Tkachuk, V.A.; Baldenkov, G.N.; Feoktistov, I.A.; Men'shikov, M.Y.; Quast, U.; Herzig, J.W. 1987: Metofenazate as a more selective calmodulin inhibitor than trifluoperazine Arzneimittel-Forschung 37(9): 1013-1017
Smedegaard, J.; Christiansen, P.; Skrumsager, B. 1981: "Treatment of obesity by femoxetine a selective 5 HT reuptake inhibitor' International Journal of Obesity 5(4): 377-378
Arcimowicz, M.; Samoliński, B.ła.; Gotlib, T.; Nyckowska, J. 2002: Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases Otolaryngologia Polska 56(4): 501-507
Laudanno, O.M.; Piombo, G.; Cesolari, J.A.M.; Godoy, A.; Rocaspana, A.; Aramberry, L. 2002: Dexketoprofene, selective cox-1 inhibitor nsaids, without gastrointestinal injury in rats Acta Gastroenterologica Latinoamericana 32(1): 17-20
Kagaya, T.; Kajiwara, A.; Nagato, S.; Akasaka, K.; Kubota, A. 1996: E2011 a novel, selective and reversible inhibitor of monoamine oxidase type a Journal of Pharmacology and Experimental Therapeutics 278(1): 243-251
Alessandri, C.; Peverini, F. 1992: Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin Minerva Medica 83(11): 677-693
Pacher, P.ál.; Kecskeméti, V.ér. 2004: Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants Orvosi Hetilap 145(8): 425-431
Kawamoto, S.; Hidaka, H. 1984: 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets Biochemical and Biophysical Research Communications 125(1): 258-264
Okamoto, S.; Yonekawa, Y.; Handa, H.; Handa, Y.; Uemura, Y.; Yano, I.; Toyoshima, M.; Iwatsuji, K.; Teraura, T.; Yamagata, S. 1986: Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(1): 251-259
Floridi, A.; Paggi, M.G.; Marcante, M.L.; Silvestrini, B.; Caputo, A.; De Martino, C. 1981: Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells Journal of the National Cancer Institute 66(3): 497-499
Read, G.W.; Kiefer, E.F. 1979: Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines Journal of Pharmacology and Experimental Therapeutics 211(3): 711-715
Niwa, T.; Maeda, K.; Shibata, M.; Yamada, K. 1988: Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome Clinical Nephrology 30(5): 276-281
Kawata, K.; Takeyoshi, I.; Iwanami, K.; Sunose, Y.; Tsutsumi, H.; Ohwada, S.; Matsumoto, K.; Morishita, Y. 2003: The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury Hepato-Gastroenterology 50(54): 1970-1974
Crown, W.H. 2000: Economic outcomes associated with tricyclic antidepressant and selective serotonin reuptake inhibitor treatments for depression Acta Psychiatrica Scandinavica. Supplementum 403: 62-66
Nemeroff, C.B. 1993: Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression Journal of Clinical Psychopharmacology 13(6 Suppl 2): 10s-17s